NEW YORK (GenomeWeb News) – Evogene today reported that its third-quarter revenues increased nearly three-fold year over year, and it swung to a profit from a loss.

The Rehovot, Israel-based firm reported total revenues of $2.6 million for the three-month period ended Sept. 30, 2009, compared to $870,000 for the third quarter of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.